Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Evaluation of Changes to Skin Microbiome With Tape-Stripped Wounds
NCT03365934 · View on ClinicalTrials.gov ↗
Study Summary
This single center, randomized, 15-day clinical trial is being conducted to assess the changes to the skin microbiome of induced wounds on the back in approximately 35 healthy adult subjects aged 18-55 years, with Fitzpatrick Skin Types I - III. Microbiome and skin physiology assessments will be completed.
Conditions Studied
Interventions
- DEVICE ADHESIVE BANDAGE #1
- DEVICE ADHESIVE BANDAGE #2
- DEVICE ADHESIVE BANDAGE #3
- DEVICE Antibacterial Bandage with 0.8% BZK
- OTHER Intact and No Bandage
Study Locations (1)
New Jersey
- TKL Research Inc. — Fair Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2018-02-12 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03365934
The ClinicalTrials.gov registry entry for NCT03365934 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 12 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 5 interventions — of which ADHESIVE BANDAGE #1 is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03365934 reports 1 study location spanning 1 distinct geographic area — top geographies include New Jersey. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03365934 about?
NCT03365934 is a clinical study titled "Evaluation of Changes to Skin Microbiome With Tape-Stripped Wounds". This single center, randomized, 15-day clinical trial is being conducted to assess the changes to the skin microbiome of induced wounds on the back in approximately 35 healthy adult subjects aged 18-55 years, with Fitzpatrick Skin Types I - III. Microbiome and skin physiology assessments will be com...
What is the current status of trial NCT03365934?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-11-20. Estimated completion is 2018-02-12.
What conditions does trial NCT03365934 study?
This clinical trial studies the following conditions: Healthy Volunteers. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03365934?
The interventions under investigation include: ADHESIVE BANDAGE #1 (DEVICE), ADHESIVE BANDAGE #2 (DEVICE), ADHESIVE BANDAGE #3 (DEVICE), Antibacterial Bandage with 0.8% BZK (DEVICE), Intact and No Bandage (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03365934?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 12 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03365934 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.